Significant Ownership of Andera Partners
- Signature - Title
- /s/ Stephane Bergez - By Stephane Bergez, Managing Partner
- Location
- Paris
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Andera Partners.
Follow Filing Activity
Follow Andera Partners and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Andera Partners
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva S.A. | Ordinary Shares, nominal value Euro 0.01 per share | 7.7% | $80,593,658 | +$10,381,814 | 14,114,476 | +15% | Andera Partners | 31 Dec 2025 |
| EVOMMUNE, INC. | Common Stock, $0.0001 par value per share | 6% | 1,897,362 | Andera Partners | 07 Nov 2025 | ||||
| MLYS | MINERALYS THERAPEUTICS, INC. | Common Stock, $0.0001 par value per share | 4.2% | $39,747,075 | 2,765,976 | Andera Partners | 30 Jun 2025 |
Schedules 13D/G Reported by Andera Partners:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.